In glioblastoma cells, glutamine metabolism provides a carbon source facilitating the use of glucose-derived carbon and TCA cycle intermediates as biosynthetic precursors [301,302] and high levels of the GS enzyme have been detected by immunohistochemical analysis of GBM clinical samples. The gene discussed is GLUL; the disease is glioblastoma.